Misonix has entered into a new five-year exclusive US distribution agreement with Anika Therapeutics Inc’s wholly owned subsidiary Anika Therapeutics Srl to sell and distribute Anika’s Hyalomatrix product, a skin substitute based on hyaluronic acid technology.

See more here:
Misonix, Anika in wound care product US distribution agreement